Abstract
Rhinovirus (RV) infections trigger asthma exacerbations. Genome-wide expression analysis of RV1A-infected primary bronchial epithelial cells from normal and asthmatic donors was performed to determine whether asthma is associated with a unique pattern of RV-induced gene expression. Virus replication rates were similar in cells from normal and asthmatic donors. Overall, RV downregulated 975 and upregulated 69 genes. Comparisons of transcriptional profiles generated from microarrays and confirmed by quantitative reverse transcription PCR and cluster analysis showed some up- and downregulated genes in asthma cells involved in immune responses (IL1B, IL1F9, IL24, and IFI44) and airway remodeling (LOXL2, MMP10, FN1). Notably, most of the asthma-related differences in RV-infected cells were also present in the cells before infection. These findings suggest that differences in RV-induced gene expression profiles of cells from normal and mild asthmatic subjects could affect the acute inflammatory response to RV, and subsequent airway repair and remodeling.
Similar content being viewed by others
Introduction
Human rhinoviruses (RVs) cause the common cold and are frequently detected in asthma exacerbations. RV typically induces neutrophilic inflammation in the upper airways of both asthmatic and non-asthmatic patients; however, in asthmatics, these infections can lead to more severe lower respiratory symptoms and reductions in lung function. Interestingly, the severity of asthma symptoms may not be related to viral load, prolonged viral shedding, or to differences in proinflammatory cytokines in the upper airway secretions.1, 2 Understanding the mechanisms provoking RV-induced airway inflammation in asthma, as well as the mechanisms linking RV infection to asthma exacerbations, may offer significant opportunities for improved disease management.
Rhinovirus infection of airway epithelial cells induces the production of a wide range of mediators involved in inflammatory and immune processes.3, 4 Transcriptional profiling of differentiated cultures of human primary bronchial epithelial (PBE) cells from two normal subjects has shown that RV infection induces a number of genes in the interferon (IFN)-β-dependent pathway.5 Furthermore, cultured epithelial cells from the airways of subjects with asthma have been found to have deficient innate immune responses to RV16 infection, characterized by increased viral replication, impaired early induction of apoptosis, and reduced type I and type III IFN production.6, 7 Collectively, these studies suggest that RV-induced airway disease could be due to asthma-related changes in gene expression in airway epithelium. The aim of this study is to compare RV-induced genome-wide gene expression profiles of cultured airway epithelial cells obtained from subjects with and without asthma to identify genes that may have a role in virus-induced asthma exacerbations.
Results
RV1A infection of PBE cells and viral RNA quantification
Primary bronchial epithelial cells (samples 7–18) from six normal subjects and six subjects with asthma ( Table 1) were inoculated with RV1A (MOI (multiplicity of infection) of 10 PFU (plaque-forming units) per cell); for one subject with asthma (sample 11), the RNA yield after infection was insufficient for further analysis. Total RNA isolated from adherent cells collected 16 h post-infection (p.i.) was analyzed using microarrays. Viral RNA was measured by quantitative reverse transcription (qRT)-PCR in growth media from the PBE cell cultures. We then repeated the process of infecting cells from these donors so that the results of the microarray experiments could be retested in separate experiments and using a different technology (qRT-PCR) to measure changes in host gene expression and viral RNA. Virus-induced cytopathic effect, as determined by light microscopy (Figure 1a), was similar in cells from normal and asthmatic subjects. In addition, there were no group-specific differences in the amount of viral RNA released into the media (including floating cells), in adherent cells, or in the total amount of RNA per well (sum of RNA in media and in the floating and adherent cells) (Figure 1b, P>0.05).
Gene expression changes in response to infection
To determine the transcriptional response of normal and asthmatic PBE cells to RV1A infection, we started by comparing genome-wide gene expression profiles in infected cells and mock-infected controls in each group. We identified a total of 1,317 probe sets corresponding to 1,044 known human genes with at least a twofold change in expression in RV-infected PBE cells vs. mock-infected control cells, in both groups. Combined lists of the 40 most highly up- and downregulated transcripts found in normal and asthmatic cells are shown in Table 2, and complete lists of genes are provided in Supplementary Tables S1 and S2 online.
The majority of affected genes were downregulated in infected cells compared with mock-infected control samples (Figure 2a). This finding is consistent with global host cell transcriptional shutoff due to RV-induced cleavages of multiple transcription factors and nuclear pore complex components.8, 9 Virus infection decreased the expression of genes related to antiviral defense (influenza virus NS1A-binding protein), apoptosis (TIA1 cytotoxic granule-associated RNA-binding protein), and regulation of cell-cycle (discs, large homolog 1 (Drosophila); ubiquitin-like, containing PHD and RING finger domains; cyclin-dependent kinase inhibitor 2B) as well as multiple proteins participating in cell metabolism (Table 2).
Genes exhibiting an increase in expression (greater than or equal to twofold) included 53 genes found in normal samples and 54 genes in the asthma group that together comprise 69 unique genes (Supplementary Table S1 online). Among the induced genes were those encoding chemoattractants for granulocytes, macrophages, and T lymphocytes (chemokine (C–X–C motif) ligand (CXCL) 1, 2, and 3; interleukin (IL) 8; and chemokine (C–C motif) ligand (CCL) 20), cytokines (colony-stimulating factors (CSF) 2 and 3; IL1F9; IL6; and IL24), decoy cytokine receptors (IL1 receptor, type II; IL1 receptor antagonist (IL1RN); IL13 receptor, α 2), and transcription factors and regulators, such as early growth response 1 (EGR1), FOS-like antigen 1 (FOSL1), nuclear factor-kappa B (NFκB) inhibitors Z and A (NFκBIZ and NFκBIA), and zinc finger CCCH-type containing 12A (Table 2). Two cytokine genes (IL1F9 and IL24) revealed more robust upregulation after RV infection in the asthma group. We also observed an increase in expression of antiviral response genes (2′-5′-oligoadenylate synthetase-like (OASL), IFN-induced protein 44 (IFI44), and IL28A (IFN, λ 2)) in normal cells and of regulators of smooth muscle tone (adrenergic receptor, β 2 (ADRB2) and endothelin 1 (EDN1)) in both groups.
We then compared these gene expression changes with results from six additional PBE cell cultures (three normal donors and three donors with asthma, Table 1) that were similarly infected in preliminary studies and explored using the HG Focus chips (Affymetrix, Santa Clara, CA) with lower probe density (>8,700 probe sets). All of the probe sets from the smaller chip are also present in the higher-density HG U133 Plus 2.0 arrays to enable comparability. Although we observed some differences in magnitude of changes between two microarray data sets (Table 2), the overall core set of virus-induced genes was similar (Supplementary Table S3 online).
Asthma-specific gene expression profiles in PBE cells
We next compared RV-induced responses in the asthma vs. normal groups. In general, patterns of gene expression were quite similar in the two groups, with a few notable exceptions. Direct comparisons of transcriptional profiles after infection identified nine genes with greater than or equal to twofold up- or downregulation in the asthma group compared with normal controls (Table 3). Genes with higher expression in the asthma group included those with functions related to inflammation (IL1F9), tumor suppressor activity (C15orf48), and airway repair and remodeling (inhibin, β A (INHBA); lysyl oxidase-like 2 (LOXL2); and matrix metallopeptidase 10 (MMP10)). In contrast, IFI44, an IFN response gene, and tumor suppressor gene, microseminoprotein β (MSMB), revealed lower expression in the asthma group. Six of these genes were also differentially expressed in mock-infected cells from asthma patients (Table 3).
Using a less stringent 1.5-fold criterion for group-specific differences in gene expression, a total of 42 genes were identified, including 32 with higher expression and 10 with lower expression in infected cells from the asthma vs. normal groups. (Supplementary Table S4 online). These genes separated the samples into four branches based on hierarchical clustering of gene expression patterns with or without viral infection (Figure 2b). Clusters of genes distinguished by this approach included those with higher expression in asthmatic cells after infection (Cluster I), those with higher expression in both mock-infected and RV-infected asthma samples (Cluster II), and those genes with increased expression in mock- or RV-infected cells from normal donors (Cluster III). Interestingly, one gene from this cluster (MSMB) revealed higher expression both at baseline (mock infection) and after RV infection in the samples from three normal female subjects.
Alternative hierarchical clustering of samples using gene expression ratios (fold differences) revealed groupings of up- and downregulated genes, but did not reveal differences related to asthma (Supplementary Figure 1 online). These findings indicate that most of the asthma-related differences in human RV-induced patterns of gene expression were also present without infection.
Functional analysis of genes affected by RV infection
Functional analysis based on the Gene Ontology classifications (Database for Annotation, Visualization and Integrated Discovery (DAVID)) showed that most genes induced by RV infection of both asthma and normal samples were related to inflammatory responses. Interestingly, there were nine RV-induced genes (CCL5, prostaglandin-endoperoxide synthase 2 (PTGS2), superoxide dismutase 2, CSF2, tumor necrosis factor (TNF), IL1RN, EDN1, ADRB2, and suppressor of cytokine signaling 1 (SOCS1)) that have been associated with asthma in genetic studies (Genetic Association Database (http://geneticassociationdb.nih.gov/)). RV infection inhibited many important biological processes in the host cell, including posttranslational protein modification, ubiquitin cycle, intracellular transport, and mRNA processing (Table 4). Of the 42 genes that were differentially expressed in the asthma vs. normal samples after RV infection, many were classified in the “defense response” and “cell–cell signaling” functional categories.
Analysis of the same data set using Gene Set Enrichment Analysis (GSEA, Broad Institute, Cambridge, MA) software revealed that RV infection of both groups upregulated genes classified in NFκB, TNF, and double-stranded RNA (poly I:C) pathways. Downregulated genes were related to metabolic pathways for pyruvate, propanoate, and steroid biosynthesis, and to the Krebs–TCA cycle. Group-specific differences in gene expression patterns after RV infection were found in “local acute inflammatory response” and “genes upregulated by NFκB” categories. Overall, both functional classification approaches revealed similar findings.
PCR validation of microarray results
To test the validity of the microarray data, additional samples of cells from normal and asthmatic volunteers were grown, and host cell mRNA was analyzed by quantitative PCR. These additional experiments confirmed virus induction of seven common upregulated genes, both in normal and asthmatic samples (Figure 3).
Of the mRNAs that appeared to be more highly expressed in asthma by microarray, similar patterns of expression were identified for several genes by qPCR (Figure 4). Notably, both INHBA and intercellular adhesion molecule 1 (ICAM1) tended to be expressed at higher levels in the uninfected asthma samples (P<0.1), and similar differences were present in infected samples. In contrast, LOXL2 was expressed at higher levels in the asthma samples (P<0.05), and was downregulated by human RV in both groups. Similar nonsignificant patterns were observed for fibronectin 1 (FN1); ADAM metallopeptidase domain 19 (ADAM19); and secreted protein, acidic, cysteine-rich (SPARC). IFI44 tended to be more upregulated in normal samples after infection. Finally, IL1F9 had similar baseline expression in the two groups, but was more highly induced by RV infection in the asthma group (P<0.05), and similar nonsignificant patterns were noted for CSF3, IL6, and IL24.
The microarray analysis identified increased expression of IL28A, but not of IFNB1, mRNA after RV infection, despite the availability of the corresponding probes in genechips. In the validation experiments using qPCR, both IFNB1 and IL28 mRNAs were upregulated after infection of both normal (7.5-fold (P=0.01) and 6.3-fold (P=0.04), respectively) and asthmatic (8.2-fold (P<0.01) and 5.9-fold (P=0.03), respectively) cells. IL29 gene was also upregulated after infection, but its very low expression levels were not sufficient for reliable comparisons. There were no significant group-specific differences in RV-induced IFN mRNA expression.
Virus infection induces expression of inflammatory cytokines in vitro
Reagents were available for a subset of differentially expressed genes to test for group-specific differences in RV-induced protein expression. We quantified protein expression of three secreted proinflammatory cytokines, IL1B, IL6, and IL8, in cell culture media of RV-infected and control samples. Virus infection increased protein levels of all three cytokines, both in normal and asthmatic samples (P<0.05), 16 h p.i. (Figure 5). IL6 tended to be upregulated in asthma samples with or without infection, but there were no significant differences between groups.
Discussion
Genome-wide transcriptional analysis was employed to determine whether asthma is associated with a unique pattern of epithelial cell gene expression after RV infection. RV1A induced characteristic cytopathic effect and efficiently replicated in PBE cell monolayers, producing similar amounts of viral RNA in cells from donors with vs. without asthma. The transcriptional response to RV infection, characterized by robust upregulation of proinflammatory pathways and downregulation of cell metabolic processes, was also similar in normal and asthmatic cells. However, both paired (infected vs. mock) and unpaired (asthma vs. normal) comparisons revealed sets of differentially expressed genes related to inflammatory mechanisms and epithelial repair that clearly separated the asthma and normal groups by hierarchical clustering. Notably, most genes that were differentially expressed in the asthma group after RV infection were also differentially expressed in uninfected cells.
Different technical approaches can be used to study responses to viral infection in vitro. We chose to use the undifferentiated cell culture model that has the advantage of allowing analysis of cells that are fairly uniform in their susceptibility to infection. Air–liquid interface cultures of the well-differentiated cells are more resistant to RV infection with a relatively small proportion of infected cells (∼5%).5, 10, 11 Therefore, the transcriptional response to RV infection is measured primarily in uninfected cells. In our system, the much higher rate of cellular infection may account for the fact that RV infection inhibits global host transcription and induces relatively few antiviral genes.12, 13
Recent studies using cultured PBE monolayers showed increased (≥10-fold) RV replication in cell monolayers obtained from subjects with atopic asthma, whereas cells from normal volunteers were more resistant to infection.6, 7 In contrast to these reports, but in a good agreement with the recent findings in differentiated PBE cell cultures,14 we found very similar amounts of viral RNA by qRT-PCR, both in supernatants, adherent cells and in total virus yields in cells from normal and asthmatic subjects. Mechanisms that have been proposed to explain enhanced RV replication in asthmatic cells in previous studies are deficient production of type I and III IFN, and impaired early induction of apoptosis. In our microarray analysis of RV1A infection, we detected a 2.1-fold induction of the type III IFN mRNA (IL28A) after RV infection in normal cells, and somewhat less (1.6-fold, P=0.115) in cells from the asthma group. Although IFNB1 expression was not detected by microarrays, we used more sensitive qPCR methodology to confirm induction of both IL28 and IFNB1 mRNAs. However, there were no significant differences in IFN expression related to asthma.
It is possible that the different findings were because of differences in experimental technique, virus strain, or subject selection. All the subjects in our studies had mild persistent atopic asthma, and we are currently conducting studies with cells obtained from donors with a more severe disease. Interestingly, IFNB1 mRNA induction after RV16 infection was not detected in another study using similar Affymetrix arrays,5 indicating a possible problem with sensitivity of this probe set.
Rhinovirus, similar to several other picornaviruses, induces gene expression shutoff in host cells through activities of two viral proteinases, 2Apro and 3Cpro, that cleave multiple translation and transcription factors, and nuclear pore complex proteins.15 Accordingly, more than 90% of differentially expressed genes in our study were reduced in expression, and many of these genes are involved in cell metabolism pathways.
The most highly upregulated genes were enriched for inflammatory mechanisms, and many of the induced factors (e.g., CSF2, CSF3, IL6, IL8, and TNF) have been previously identified in experimental models and clinical infections3, 4, 16, 17 and shown to have roles in airway inflammation.18, 19, 20, 21 Additional inflammatory factors were also upregulated by infection, including cytokines (IL1F9 and IL24) and transcription factors that regulate inflammatory responses in airways (EGR1 and FOSL1).22, 23, 24, 25 Notably, some of the upregulated cytokines and their receptors (e.g., TNF, CCL5, CSF2, and IL1RN), and inflammatory factors (SOCS1, PTGS2, serpin peptidase inhibitor B2 (SERPINB2), and EDN1) have been linked to asthma in genetic and microarray studies, and in mouse models of asthma.26, 27, 28, 29, 30, 31, 32, 33, 34
The main goal of our study was to identify genes that were differentially expressed with RV infection in the asthma vs. normal cell groups. Two categories of factors were identified by the analysis and hierarchical clustering: (i) different expression levels at baseline and after infection (most common), and (ii) similar expression at baseline and different expression after infection. The first category included genes implicated in airway repair and remodeling (INHBA, MMP10, LOXL2, FN1, and SPARC), and interestingly, ICAM1, which is used as a receptor by major group RV. These findings provide evidence that epithelial cells from individuals with asthma may be fundamentally different at baseline in the absence of infection. There were relatively few genes that were differentially expressed in asthmatic cells after infection but not at baseline (IL1F9, CSF3, IFI44, and IL24). Notably, IL1F9 is upregulated in PBE cells after microbial exposure,22 and IL24 is the key cytokine to trigger the upregulation of class I IFNs.35 Additional clinical studies are required to determine whether these cytokines contribute to the increased morbidity of RV infections in patients with asthma.
One of the limitations of our study is that the differences in expression found between normal and asthmatic cells were not statistically significant after correcting for multiple comparisons, and we elected to test the validity of the microarray findings by conducting additional independent experiments that were analyzed by qRT-PCR. Overall, the two techniques showed very good correlation, both in terms of direction and magnitude of changes. Moreover, gene expression changes in six additional PBE cell cultures tested in preliminary studies using HG Focus GeneChips were consistent with those discussed in this paper. In addition to mRNA expression, we confirmed that protein expression of three secreted cytokines (IL1B, IL6, and IL8) was induced in cell culture media after RV infection, consistent with microarray and qRT-PCR results. Owing to the limited number of replicates, it should be acknowledged that the chances of a type II statistical error are high, and there certainly could be small asthma-related differences in the RV-induced gene expression patterns that were not detected in our study.
In addition to confirmation of our findings by statistical and quantitative means, we compared them with those of other published studies involving microarray analysis. Gene expression profiles in nasal epithelial scrapings after experimental RV16 infection of normal volunteers have showed upregulation of chemokines, signaling molecules, IFN-responsive genes, and antivirals, and a number of these factors (CCL20, SOCS1, SOCS3, and OASL) were also identified in our study of isolated epithelial cells.36 Microarrays have recently been used to analyze inflammatory responses in asthma after allergen challenge, neuropeptide stimulation, and corticosteroid resistance.37, 38, 39 In spite of significant differences between cell types and/or stimulus, we found overlap between RV-induced changes in gene expression, and those found in brushings of mild asthmatics after allergen challenge (GOS2; IL1RN, IL1B, IL8, SERPINB2, MMP10, and SPARC),37 after neuropeptide stimulation of epithelial cells (INHBA, MMP10, EGR1, SERPINB2, FOSL1, CXCL2, IL8, and PTGS2),38 and in bronchoalveolar lavage cells from subjects with corticosteroid-resistant asthma (IL6, TNF, IL1B, CCL20, IL8, CXCL1, CXCL2, CXCL3, EGR1, and TNFAIP3).39 Taken together, these similarities at transcriptional level could show the existence of some common mechanisms of asthma.
Overall, we showed similar RV replication rates and transcriptional response to RV1A in normal and asthmatic PBE cells. These findings suggest that factors outside of the epithelial cell, such as airway inflammation and abnormal airway structure and physiology, are important contributors to more severe clinical outcomes of common cold infections in asthma. Even so, our studies identified a subset of epithelial cell genes that were differentially expressed in asthma compared with those in normal subjects with functions related to inflammatory pathways, and regulation of airway repair and extracellular matrix. Further characterization of these potential asthma-related differences in the epithelial cell response to viral infection should provide a better understanding of molecular mechanisms of virus-induced asthma exacerbations.
Methods
Cell culture and viral infection. Human PBE cells were obtained from the bronchial brushings of normal and asthmatic individuals (Table 1). Subjects in the asthma group were required to have doctor-diagnosed asthma, and either methacholine PC20 (provocative concentration of methacholine causing a 20% fall in forced expiratory volume in 1 sec (FEV1)) ≤8 mg ml−1 or at least 12% reversibility in FEV1 after administration of albuterol. Prick skin testing was performed using a panel of 15 common allergens, including grass and tree pollens, dust, dog and cat hair, and a positive response was defined as a wheal size greater than the histamine-negative control. Cells were grown at 37 °C (5% CO2) in bronchial epithelial growth medium (BEGM, Lonza, Walkersville, MD). Purified and concentrated RV1A was diluted in bronchial epithelial growth medium with a reduced concentration of hydrocortisone (10−8 M) just before infection. One six-well plate of PBE cells from each patient was either infected with RV1A (10 PFU per cell) or mock-infected with medium alone. At collection (16 h p.i.), cell monolayers were washed thrice with phosphate-buffered saline and lysed by adding TRIzol Reagent (Invitrogen, Carlsbad, CA). Supernatant and cell lysate samples were stored in microcentrifuge tubes at −80 °C until RNA isolation. Detailed information about the cell culture and infection procedures is provided in the Supplementary Materials online. Preliminary experiments to determine the optimal virus dose (MOI of 2, 10, and 50 PFU per cell) and time p.i. (8, 16, and 24 h) were conducted with PBE cells obtained by enzymatic digestion of bronchi from two lung transplants40 and used at passages 2–3. Cells were grown in bronchial epithelial growth media and infected with RV1A as described above.
Optimization of RV infection procedure for microarray analysis. The minor group RV1A was chosen for this study because minor group viruses infect a much larger percentage of cultured epithelial cells compared with major group viruses,40 and RV1A and RV16 strains have been shown to induce similar expression changes in host cells in vitro.5 We carried out preliminary experiments to establish the optimal infectious dose of the virus and time p.i. that is the most informative for microarray analysis. The major criterion was to have a productive infection with clear cytopathic effect in host cells, in parallel with sufficient total RNA yield and quality for use as starting material in GeneChip analysis. Previous studies from our laboratory using HG Focus array (Affymetrix) and cells from three normal subjects showed that the maximal gene expression changes were observed 16 h p.i., and the vast majority of mRNAs upregulated earlier (4 and 8 h p.i.) remained induced at later time points (unpublished data). We then used this time point to compare different virus doses of infection in PBE cells from two normal lung donors. Infection at MOI of 10 PFU per cell caused distinctive cytopathic effect with more than 50% of cells being rounded and detached, while producing sufficient amount of total RNA (≥10 μg) from adherent cells suitable for GeneChip hybridization (Supplementary Figure 2 online).
RNA extraction and microarray hybridization. Total RNA was isolated from the frozen TRIzol lysates according to manufacturer's protocol, and then purified by the RNeasy Mini Kit (Qiagen, Hilden, Germany). A total of 10 μg of purified total RNA samples were submitted to the University of Wisconsin–Madison Gene Expression Center (Madison, WI) for labeling and hybridization. Following all appropriate protocols and procedures for eukaryotic total RNA quality control, labeling, and fragmentation, the biotin-labeled cRNA samples were hybridized to either the Human Genome Focus GeneChip Array (samples 1–6) or Human Genome U133 Plus 2.0 GeneChip arrays (samples 7–18) (Affymetrix) according to the manufacturer's protocols.
Microarray data analysis. The CEL files extracted and processed with Affymetrix GeneChip Operating software (GCOS) were analyzed using Bioconductor41 package “affy” based on R 2.4.1 statistical software (www.r-project.org). Log2-transformed expression values across all the chips were extracted using the Robust Multichip Average method.42 Processing with Robust Multichip Average method involved background correction, probe-level quantile normalization across all the chips, and expression summarization. Statistical analysis for detecting differentially expressed genes in two sample comparisons involved either a paired t-test or a two independent sample t-test. We used the Benjamini–Hocberg false discovery rate-controlling procedure to account for multiple testing.43 Details are provided in the online supplement. Hierarchical clustering using centroid linkage method was performed on the basis of the selected gene sets using Cluster 3.044 (Human Genome Center, Institute of Medical Science, University of Tokyo, Japan) and visualized using JavaTreeView 1.1.1.45 http://jtreeview.sourceforge.net The microarray data have been submitted to Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/projects/geo/) and assigned the accession number GSE13396.
Functional analysis of differentially expressed genes. Annotation and functional clustering of selected probe sets were performed using the DAVID (National Cancer Institute at Frederick, Frederick, MD) web-accessible program.46 Genes with multiple corresponding probe sets were analyzed only when all probe sets showed consistent changes in the same direction (up- or downregulation). The data were analyzed using the “Gene Functional Classification” tool using the “High” classification stringency setting.
In addition, pathway analysis was performed using Gene Set Enrichment Analysis (GSEA) software47 that determines whether an a priori defined set of genes shows statistically significant differences between two biological states (e.g., mock and virus infection). We have performed GSEA on our pre-ranked list of genes for each comparison of interest. The genes were ranked on the basis of their t-test statistics, and GSEA was run in the weighted mode. The main feature of this type of analysis is that it can detect subtle changes present in the data set.
qRT-PCR validation of microarray results. First-strand cDNA synthesis was performed using the RT2 First Strand Kit (SuperArray, Frederick, MD). Human RT2 RNA QC PCR Array (SuperArray) was used to assess the quality and integrity of purified RNAs. A total of 11 selected genes differentially expressed in asthma were targeted using custom-designed RT2 Profiler PCR Array (SuperArray). The list of target genes, amplicon size, and reference positions of SuperArray primers are shown in Supplementary Table S5 online. Expression of 11 additional genes was tested using primers shown in Supplementary Table S6 online. RT2 Real-Time SYBR Green/ROX PCR master mix (SuperArray) was used to perform the reactions. Fold differences were determined by the 2−ΔΔCt method. RV RNA was quantified in supernatants and adherent cells after infection using the two primers and probes described previously.48 Additional details on qRT-PCR are provided in the online supplement.
Protein analysis. Supernatants from RV- and mock-infected cell cultures were assayed for IL8, IL1B, and IL6 proteins. IL8 chemokine concentrations were determined by sandwich ELISA using anti-human IL8 monoclonal antibody in combination with biotinylated polyclonal detection antibody and recombinant IL-8 protein as the standard (R&D systems, Minneapolis, MN). IL1B and IL6 cytokine levels were assessed using human IL1B and IL6 Beadmates assays (Millipore, Temecula, CA) according to the manufacturer's instructions. Luminex 100 (Luminex Corporation, Austin, TX) instrument was used to run plates and generate quantitative data. Sensitivity of the IL1B and IL6 assays for the protocol used was 8.2 pg ml−1.
Statistical analysis. Student's t-test was used to determine the statistical significance of the 5 data. Significance was defined at P<0.05. Statistic calculations were carried out by SigmaPlot 11.0 software (Systat Software, San Jose, CA).
Disclosure
The authors declare no conflict of interest.
Accession codes
References
Corne, J.M. et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359, 831–834 (2002).
van Elden, L.J. et al. Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract. J. Clin. Virol. 41, 116–121 (2008).
Hansbro, N.G., Horvat, J.C., Wark, P.A. & Hansbro, P.M. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol. Ther. 117, 313–353 (2008).
Kallal, L.E. & Lukacs, N.W. The role of chemokines in virus-associated asthma exacerbations. Curr. Allergy Asthma Rep. 8, 443–450 (2008).
Chen, Y. et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am. J. Respir. Cell Mol. Biol. 34, 192–203 (2006).
Wark, P.A. et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937–947 (2005).
Contoli, M. et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 12, 1023–1026 (2006).
Amineva, S.P., Aminev, A.G., Palmenberg, A.C. & Gern, J.E. Rhinovirus 3C protease precursors 3CD and 3CD′ localize to the nuclei of infected cells. J. Gen. Virol. 85, 2969–2979 (2004).
Gustin, K.E. & Sarnow, P. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J. Virol. 76, 8787–8796 (2002).
Lopez-Souza, N. et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am. J. Physiol Lung Cell Mol. Physiol. 286, L373–L381 (2004).
Jakiela, B., Brockman-Schneider, R., Amineva, S., Lee, W.M. & Gern, J.E. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am. J. Respir. Cell Mol. Biol. 38, 517–523 (2008).
Neznanov, N. et al. Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J. Biol. Chem. 280, 24153–24158 (2005).
Kotla, S., Peng, T., Bumgarner, R.E. & Gustin, K.E. Attenuation of the type I interferon response in cells infected with human rhinovirus. Virology 374, 399–410 (2008).
Lopez-Souza, N. et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J. Allergy Clin. Immunol. 123, 1384–1390 (2009).
Lyles, D.S. Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol. Mol. Biol. Rev. 64, 709–724 (2000).
Newcomb, D.C. et al. Cooperative effects of rhinovirus and TNF-/{alpha/} on airway epithelial cell chemokine expression. Am. J. Physiol Lung Cell Mol. Physiol. 293, L1021–L1028 (2007).
Gern, J.E., Vrtis, R., Grindle, K.A., Swenson, C. & Busse, W.W. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am. J. Respir. Crit. Care Med. 162, 2226–2231 (2000).
Dodge, I.L., Carr, M.W., Cernadas, M. & Brenner, M.B. IL-6 production by pulmonary dendritic cells impedes Th1 immune responses. J. Immunol. 170, 4457–4464 (2003).
Doganci, A. et al. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115, 313–325 (2005).
Cates, E.C. et al. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J. Immunol. 173, 6384–6392 (2004).
Yamashita, N. et al. Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cell Immunol. 219, 92–97 (2002).
Vos, J.B. et al. Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense. Physiol Genomics 21, 324–336 (2005).
Silverman, E.S. et al. The transcription factor early growth-response factor 1 modulates tumor necrosis factor-alpha, immunoglobulin E, and airway responsiveness in mice. Am. J. Respir. Crit. Care Med. 163, 778–785 (2001).
Ingram, J.L. et al. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J. Immunol. 177, 4141–4148 (2006).
Adiseshaiah, P., Vaz, M., Machireddy, N., Kalvakolanu, D.V. & Reddy, S.P. A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion. J. Cell Physiol. 216, 405–412 (2008).
Szczeklik, W., Sanak, M. & Szczeklik, A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J. Allergy Clin. Immunol. 114, 248–253 (2004).
Buckova, D., Izakovicova, H.L. & Vacha, J. Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy 57, 446–448 (2002).
Zhu, G. et al. Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations. Genes Immun. 9, 23–29 (2008).
Woodruff, P.G. et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA 104, 15858–15863 (2007).
Ramadas, R.A. et al. IL-1 receptor antagonist as a positional candidate gene in a murine model of allergic asthma. Immunogenetics 58, 851–855 (2006).
Kumar, A., Gupta, V., Changotra, H., Sarin, B.C. & Sehajpal, P.K. Tumor necrosis factor-alpha and transforming growth factor-beta1 polymorphisms in bronchial asthma. Indian J. Med. Sci. 62, 323–330 (2008).
Kamali-Sarvestani, E., Ghayomi, M.A. & Nekoee, A. Association of TNF-alpha-308 G/A and IL-4-589 C/T gene promoter polymorphisms with asthma susceptibility in the south of Iran. J. Investig. Allergol. Clin. Immunol. 17, 361–366 (2007).
Lachheb, J., Chelbi, H., Hamzaoui, K. & Hamzaoui, A. Association between RANTES polymorphisms and asthma severity among Tunisian children. Hum. Immunol. 68, 675–680 (2007).
Harada, M. et al. Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. Am. J. Respir. Cell Mol. Biol. 36, 491–496 (2007).
Ekmekcioglu, S., Mumm, J.B., Udtha, M., Chada, S. & Grimm, E.A. Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24. Cytokine 43, 34–44 (2008).
Proud, D. et al. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am. J. Respir. Crit. Care Med. 178, 962–968 (2008).
Lilly, C.M., Tateno, H., Oguma, T., Israel, E. & Sonna, L.A. Effects of allergen challenge on airway epithelial cell gene expression. Am. J. Respir. Crit. Care Med. 171, 579–586 (2005).
Vendelin, J. et al. Downstream target genes of the neuropeptide S-NPSR1 pathway. Hum. Mol. Genet. 15, 2923–2935 (2006).
Goleva, E. et al. Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J. Allergy Clin. Immunol. 122, 550–559 (2008).
Schroth, M.K. et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 20, 1220–1228 (1999).
Gentleman, R.C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
Irizarry, R.A. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995).
de Hoon, M.J., Imoto, S., Nolan, J. & Miyano, S. Open source clustering software. Bioinformatics 20, 1453–1454 (2004).
Saldanha, A.J. Java Treeview—extensible visualization of microarray data. Bioinformatics. 20, 3246–3248 (2004).
Dennis, G. Jr . et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4, 3 (2003).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
Mosser, A.G. et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am. J. Respir. Crit. Care Med. 171, 645–651 (2005).
Acknowledgements
We thank Dr Wai-Ming Lee for providing us the purified and concentrated human rhinovirus strain 1A, and Ms. Kathryn Schmit for her technical assistance with qRT-PCR testing. This work was supported by grants NIAID/NIH U19 AI070503-01, NHLBI/NIH P01 HL70831-01, and NHLBI R01HL080412 from the National Institutes of Health (Bethesda, MD).
Author information
Authors and Affiliations
Corresponding author
Additional information
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
Supplementary information
Rights and permissions
About this article
Cite this article
Bochkov, Y., Hanson, K., Keles, S. et al. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 3, 69–80 (2010). https://doi.org/10.1038/mi.2009.109
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mi.2009.109
This article is cited by
-
Different expression levels of interleukin-36 in asthma phenotypes
Allergy, Asthma & Clinical Immunology (2024)
-
IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice
Communications Biology (2021)
-
Altered transcriptional and chromatin responses to rhinovirus in bronchial epithelial cells from adults with asthma
Communications Biology (2020)
-
IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia
Mucosal Immunology (2017)
-
Interleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses
Scientific Reports (2017)